跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,430 条关于
“oral PCSK9”
全部
28,430
临床试验
21,536
药物
1,255
机构
83
资讯
5,556
2个月前
FDA Approves Merck's Oral PCSK9 Drug, a First-in-Class Cholesterol Treatment
去年
AstraZeneca's Oral PCSK9 Inhibitor Shows Promise in Phase 1 Trial
6个月前
Merck Presents Positive Phase 3 Data for Oral PCSK9 Inhibitor Enlicitide at ACC.26
去年
Merck's Enlicitide Shows Promise as First Oral PCSK9 Inhibitor in Phase 3 Trials
2年前
AstraZeneca Unveils Oral Small Molecule PCSK9 Inhibitor AZD0780
9个月前
Merck Announces Historic Agreement with U.S. Government to Expand Drug Access and Introduce First Oral PCSK9 Inhibitor
3年前
Merck Launches First Phase 3 Program for Oral PCSK9 Inhibitor MK-0616 to Treat High Cholesterol
上个月
Novel Hypercholesterolemia Drugs Market to Reach USD 42.8 Billion by 2036 as Oral PCSK9 Inhibition and Gene Editing Expand Treatment Options
去年
FDA Approves First Triple Combination Hypertension Pill as June 2025 Delivers Major Cardiovascular Advances
5个月前
Merck's Oral Cholesterol Drug Enlicitide Shows 64.6% LDL Reduction in Late-Stage Trial
第 1 页,共 556 页
上一页
下一页